Skip to main content

Research Repository

Advanced Search

The detection of oesophageal varices using a novel, disposable, probe-based transnasal endoscope: a prospective diagnostic pilot study

GUHA, NEIL; Sami, Sarmed S.; Ragunath, Krish; Wilkes, Emilie A.; James, Martin; Mansilla‐Vivar, Rodrigo; Ortiz‐Fernández‐Sordo, Jacobo; White, Jonathan; Khanna, Amardeep; Coletta, Marina; Samuel, Sunil; Aithal, Guruprasad P.

The detection of oesophageal varices using a novel, disposable, probe-based transnasal endoscope: a prospective diagnostic pilot study Thumbnail


Authors

Profile image of NEIL GUHA

NEIL GUHA neil.guha@nottingham.ac.uk
Professor of Hepatology

Sarmed S. Sami

Krish Ragunath

Emilie A. Wilkes

Martin James

Rodrigo Mansilla‐Vivar

Jacobo Ortiz‐Fernández‐Sordo

Jonathan White

Amardeep Khanna

Marina Coletta

Sunil Samuel



Abstract

Background & Aims
Screening for oesophageal varices (OV) using conventional oesophagogastroduodenoscopy (C-OGD) is invasive and requires costly monitoring, recovery, and decontamination facilities. We aimed to evaluate the technical feasibility, acceptability and accuracy of a novel, portable and disposable office-based transnasal endoscope (EG Scan™) compared to C-OGD as the reference standard.

Methods
This was a prospective cohort study. Consecutive adult patients with cirrhosis were invited to participate. All subjects underwent the two procedures on the same day performed by two endoscopists in a blinded design. Patients completed preference and validated tolerability (10-point visual analogue scale (VAS)) questionnaires on day 0 and day 14 post procedures.

Results
Forty-five of 50 patients (90%) completed both interventions. Mean age was 59 years and OV prevalence was 49%.

Patients reported higher preference (percentage) and better experience (mean VAS) with EG Scan compared to C-OGD on day 0 (76.5% vs. 23.5%, P < 0.001; 7.8 vs. 6.8, P = 0.058, respectively) and day 14 (77.8% vs. 22.2%, P < 0.001; 7.0 vs. 5.5, P = 0.0013 respectively). Sensitivity and specificity of the EG Scan for the diagnosis of any size OV were 0.82 (95% confidence interval (CI) 0.60–0.95), and 0.78 (95% CI 0.56–0.93) respectively. Corresponding values for the diagnosis of clinically significant (medium/large) OV were 0.92 (95% CI 0.62–1.0), 0.97 (95% CI 0.84–1.0) respectively. No serious adverse events occurred.

Conclusions
EG Scan accuracy was higher for the diagnosis of medium/large OV compared to any size OV. Patients' preference and overall experience of the EG Scan was favourable compared to C-OGD 14 days after procedures.

Journal Article Type Article
Online Publication Date Apr 28, 2016
Publication Date 2016-11
Deposit Date Jun 12, 2018
Publicly Available Date Apr 25, 2024
Journal Liver International
Print ISSN 1478-3223
Electronic ISSN 1478-3231
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 36
Issue 11
Pages 1639-1648
DOI https://doi.org/10.1111/liv.13152
Public URL https://nottingham-repository.worktribe.com/output/1117050
Publisher URL https://onlinelibrary.wiley.com/doi/epdf/10.1111/liv.13152
PMID 27125510